The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
A tertiary amino compound that is propylamine which is substituted at position 3 by a pyridin-2-yl group and a p-chlorophenyl group and in which the hydrogens attached to the nitrogen are replaced by methyl groups. A histamine H1 antagonist, it is used to relieve the symptoms of hay fever, rhinitis, urticaria, and asthma.
Chlorpheniramine binds to and results in decreased activity of HRH1 protein Chlorpheniramine results in decreased activity of HRH1 protein Chlorpheniramine binds to and results in decreased activity of HRH1 protein; Chlorpheniramine inhibits the reaction [HRH1 results in decreased susceptibility to Morphine] Chlorpheniramine binds to and results in decreased activity of HRH1 protein; Chlorpheniramine inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of HRH1 mRNA]
Chlorpheniramine results in decreased activity of KCNH2 protein Chlorpheniramine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] Chlorpheniramine affects the activity of KCNH2 protein
Chlorpheniramine results in decreased activity of MPO protein Famotidine promotes the reaction [Chlorpheniramine results in decreased activity of MPO protein]
Chlorpheniramine inhibits the reaction [Histamine results in increased expression of MUC5AC mRNA]; Chlorpheniramine inhibits the reaction [Histamine results in increased expression of MUC5AC protein]
Chlorpheniramine affects the reaction [SLC22A2 protein results in increased uptake of Tetraethylammonium] Chlorpheniramine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]